IRIS
CHIEFFO, ALAIDE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 874
NA - Nord America 621
AS - Asia 401
SA - Sud America 7
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.906
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 616
SE - Svezia 389
RU - Federazione Russa 261
SG - Singapore 253
IT - Italia 122
CN - Cina 116
IE - Irlanda 32
FI - Finlandia 27
DE - Germania 15
GB - Regno Unito 14
IR - Iran 9
HK - Hong Kong 7
PL - Polonia 7
BR - Brasile 5
CA - Canada 5
IN - India 4
TR - Turchia 3
DK - Danimarca 2
ES - Italia 2
IQ - Iraq 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
AR - Argentina 1
AT - Austria 1
EU - Europa 1
FR - Francia 1
HU - Ungheria 1
KR - Corea 1
PH - Filippine 1
PK - Pakistan 1
UY - Uruguay 1
Totale 1.906
Salva come PNG Salva come JPEG
Città #
Lawrence 149
Princeton 149
Singapore 149
Moscow 94
Shanghai 72
New York 58
Milan 56
Ashburn 37
Dublin 32
Helsinki 25
Boardman 21
Seattle 15
Rome 7
Los Angeles 5
Santa Clara 5
Krakow 4
Tianjin 4
Washington 4
Ankara 3
Bari 3
Borås 3
Clifton 3
Edinburgh 3
Edmonton 3
Gatchina 3
Hanover 3
Loano 3
Mikołów 3
São Paulo 3
Atrani 2
Bangkok 2
Barletta 2
Bethesda 2
Bologna 2
Castenaso 2
Copenhagen 2
Ferrara 2
Hong Kong 2
Lappeenranta 2
Mascalucia 2
Pisa 2
Pistoia 2
Reggio Emilia 2
Rockville 2
St Petersburg 2
Taipei 2
Torre del Lago Puccini 2
Vadodara 2
Arezzo 1
Aurora 1
Bene Vagienna 1
Buenos Aires 1
Chandler 1
Cheyenne 1
Council Bluffs 1
Dalsjoefors 1
Dzerzhinsk 1
Earls Court 1
Gavirate 1
Guangzhou 1
Gurgaon 1
Islington 1
Makati City 1
Modena 1
Montevideo 1
Montreal 1
Mountain View 1
Nam-gu 1
Napoli 1
Novara 1
Omsk 1
Padova 1
Pune 1
Quetta 1
Raleigh 1
Rende 1
San Francisco 1
San Zeno Naviglio 1
Sesto San Giovanni 1
Southwark 1
Springfield 1
Tehran 1
Temecula 1
Toronto 1
Vienna 1
Totale 994
Salva come PNG Salva come JPEG
Nome #
A systematic transoesophageal echocardiography study of suture-mediated percutaneous patent foramen ovale closure 35
A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation 27
Prognostic impact of mitral regurgitation changes after TAVI 25
Anticoagulation for Percutaneous Ventricular Assist Device-Supported Cardiogenic Shock: JACC Review Topic of the Week 22
Ultrasound-assisted thrombolysis in high and intermediate-high risk pulmonary embolism patients with contraindications to systemic thrombolysis: a retrospective multicentre experience 22
Analysis of a Low Dose Protocol to Reduce Patient Radiation Exposure During Percutaneous Coronary Interventions 22
A Comparison of the Femoral and Radial Crossover Techniques for Vascular Access Management in Transcatheter Aortic Valve Implantation: The Milan Experience 21
5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience 20
Interatrial Septal Tear After Patent Foramen Ovale Closure With the NobleStitch Device 20
Impact of Ascending Aorta Dilation on Mid-Term Outcome After Transcatheter Aortic Valve Implantation 20
A challenging case of transcatheter aortic prosthesis dysfunction: Endocarditis or thrombosis? 19
A complex valve anatomy for mitraclip: Forme fruste of Barlow’s disease with cleft 19
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up 18
A novel supra-annular plane that predicts TAVI prosthesis anchoring in raphe-type bicuspid aortic valve disease: the LIRA plane 18
Does the STS-PROM Score or the Logistic EuroSCORE Predict Outcomes Following Transcatheter Aortic Valve Replacement at 30 Days: the Milan Experience 18
A Comparison Between First-Generation and Second-Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Propensity-Matched Single-Center Experience 17
A Comparison Between New Generation And First Generation Transcatheter Aortic Valve Implantation (TAVI) Devices: A Single Centre Experience 17
Sex and Transcatheter Aortic Valve Implantation: Impact of Female Sex on Clinical Outcomes 16
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques 16
A comparison of the fully repositionable and retrievable Boston Lotus and direct flow medical valves for the treatment of severe aortic stenosis: A single center experience 16
Impact of Left Ventricular Outflow Tract Calcification on Pacemaker Implantation After Transcatheter Aortic Valve Implantation With Second-Generation Devices 16
Impact of Post-Percutaneous Coronary Intervention Fractional Flow Reserve Measurement on Procedural Management and Clinical Outcomes: The REPEAT-FFR Study 15
Coronary Protection to Prevent Coronary Obstruction During TAVR 15
Frequency of slow coronary flow following successful stent implantation and effect of Nitroprusside 15
Mid-term clinical outcomes after bailout drug-eluting stenting for suboptimal drug-coated balloon results: Insights from a Milan registry 14
Sex Differences in Use of Intracoronary Imaging in Patients Undergoing Percutaneous Coronary Intervention 14
Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry 14
A comparison Of The Femoral And Radial Crossover Techniques For Vascular Access Management In Transcatheter Aortic Valve Implantation: The Milan Experience 14
Tricento Transcatheter Heart Valve for Severe Tricuspid Regurgitation: Procedural Planning and Technical Aspects 14
Need for permanent pacemaker implantation after corevalve, sapien and surgical aortic valve replacement: incidence, time course and predictive factors 14
ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes 14
Drug eluting stent implantation versus bypass surgery in unprotected left stenosis: A single center experience 13
Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience 13
Radial Versus Femoral Access for the Treatment of Left Main Lesion in the Era of Second-Generation Drug-Eluting Stents 13
Percutaneous exclusion of left ventricular pseudoaneurysm 13
Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management 13
Levelling the field of cardiovascular disease in women 12
Heyde's Syndrome Incidence and Outcome in Patients Undergoing Transcatheter Aortic Valve Implantation 12
Managing Patients With an Indication for Anticoagulant Therapy After Transcatheter Aortic Valve Implantation 12
Incidence and Management of Restenosis After Treatment of Unprotected Left Main Disease With Second-Generation Drug-Eluting Stents (from Failure in Left Main Study With 2nd Generation Stentsâ Cardiogroup III Study) 12
FEVER AFTER TAVI (TRANSCATHETER AORTIC VALVE IMPLANTATION): IS IT INFLAMMATION OR INFECTION? 12
A High Dose of Adenosine to Induce Transient Asystole for Valvuloplasty in Patients Undergoing Transcatheter Aortic Valve Implantation (TAVI): Is it a Valid Alternative to Rapid Pacing? A Prospective Pilot Study 12
A New Tool to Manage Side-Branch Occlusion After Covered-Stent Implantation for Vascular Complications The Neocarina Reconstruction Technique 12
"Procedural trauma risks longitudinal shortening of the Promus Element™ stent platform" 11
Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation 11
Impella RP for Patients with Acute Right Ventricular Failure and Cardiogenic Shock: A Subanalysis from the IMP-IT Registry 11
STEMIs and a Closer Look at MINOCA During the COVID-19 Pandemic 11
Transcatheter aortic bioprosthesis durability: A single center experience 11
Trascatheter Aortic Valve Implantation Outcomes With Self-Expandable and Balloon-Expandable Devices in Patients with Mixed Aortic Valve Stenosis 11
Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience) 11
Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients â results from the BELLO (balloon elution and late loss optimization) trial 11
Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study 11
Radiation exposure and contrast agent reduction during transcatheter aortic valve implantation: An ongoing experience 11
Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation 11
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 11
Comparison of Percutaneous Coronary Intervention (With Drug-Eluting Stents) Versus Coronary Artery Bypass Grafting in Women With Severe Narrowing of the Left Main Coronary Artery (from the Women-Drug-Eluting stent for LefT main coronary Artery disease Registry) 11
Corrigendum: “Long-Term (≥10 Years) Safety of Percutaneous Treatment of Unprotected Left Main Stenosis With Drug-Eluting Stents” (The American Journal of Cardiology 118 (2016) (32–39), (S000291491630488X), (10.1016/j.amjcard.2016.04.007)) 10
Angiographic analysis of pattern of late luminal loss in sirolimus- and paclitaxel-eluting stents 10
17-beta-estradiol eluting stent versus phosphorylcholine-coated stent for the treatment of native coronary artery disease 10
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1-epidemiology, pathophysiology, and diagnosis 10
Impact of Clinical and Lesion Features on Outcomes After Percutaneous Coronary Intervention in Bifurcation Lesions 10
Preliminary outcomes after transcatheter aortic valve implantation in patients with systemic sclerosis 10
The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation 10
Mid-Term Clinical Outcomes Following Percutaneous Mitral Valve Edge-to-Edge Repair 10
Drug eluting stent implantation versus bypass surgery in unprotected left main stenosis: A single center experience 10
Rate of progression of ascending aorta dilatation in patients with bicuspid and tricuspid aortic valve 10
Angiographic patterns of restenosis after paclitaxel-eluting stent implantation 10
A novel approach to chronic total occlusions: the crosser system 10
Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 H) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement 10
Bleeding risk differences after TAVR according to the ARC-HBR criteria: insights from SCOPE 2 9
Sex-Specific Considerations in Degenerative Aortic Stenosis for Female-Tailored Transfemoral Aortic Valve Implantation Management 9
Outcomes in Patients With Early Menopause Who Underwent Transcatheter Aortic Valve Implantation 9
Real-Time Intravascular Ultrasound Guidance for Ultra-Low Contrast Complex Bifurcation Percutaneous Coronary Intervention 9
The impact of chronic kidney disease severity on clinical outcomes after current generation drug-eluting stent implantation for left main distal bifurcation lesions: the Milan and New-Tokyo registry 9
Implementation of a Low Frame-Rate Protocol and Noise-Reduction Technology to Minimize Radiation Dose in Transcatheter Aortic Valve Replacement 9
Observational Multicenter Registry of Patients Treated with IMPella Mechanical Circulatory Support Device in ITaly: The IMP-IT Registry 9
Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries 9
Polymer-Free Biolimus-Eluting Stents or Polymer-Based Zotarolimus-Eluting Stents for Coronary Bifurcation Lesions 9
Successful percutaneous anterograde transcatheter valve-in-valve implantation in the mitral position 9
Risk factors and clinical significance of intra-procedural haemodynamic instability in patients undergoing transcatheter aortic valve implantation 9
Early Outcomes With Direct Flow Medical Versus 1 degrees-Generation Transcatheter Aortic Valve Devices: A Single-Center Propensity-Matched Analysis 9
Five Year Outcomes Following PCI with DES Implantation vs CABG for Unprotected Left Main Coronary Artery Lesions: Milan Experience 9
Impact of Mean Platelet Volume on Combined Safety Endpoint and Vascular and Bleeding Complications following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation 9
Transcatheter vs surgical aortic valve replacement in intermediate-surgical-risk patients with aortic stenosis: A propensity score-matched case-control study 9
Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation 9
Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis: Searching an Explanation and a Solution 9
Incidence, Patterns, and Associations Between Dual-Antiplatelet Therapy Cessation and Risk for Adverse Events Among Patients With and Without Diabetes Mellitus Receiving Drug-Eluting Stents: Results From the PARIS Registry 9
OUTCOMES FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARING EDWARDS SAPIEN WITH MEDTRONIC COREVALVE REVALVING SYSTEM DEVICES: RESULTS FROM THE MILAN REGISTRY 9
Five Year Outcomes Following Drug-eluting Stents Implantation vs. Coronary Artery Bypass Graft Surgery for Unprotected Left Main Coronary Artery Lesions: Milan Experience 9
Predictors of cardiac death in patients with coronary chronic total occlusion not revascularized by PCI 9
Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Severely Stenotic Bicuspid Versus Tricuspid or Nonbicuspid Valves 9
Response to letters regarding article, "Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: A single-center experience" 9
Percutaneous transjugular tricuspid valve-in-valve implantation for degenerated surgical bioprosthetic valve 9
Usefulness of Predilation Before Transcatheter Aortic Valve Implantation 9
Early outcomes with direct flow medical versus first-generation transcatheter aortic valve devices: A single-center propensity-matched analysis 9
Incidence, Management, and Outcomes of Cardiac Tamponade During Transcatheter Aortic Valve Implantation A Single-Center Study 9
Impact of Left Main Calcium With Chronic Kidney Disease on Outcomes After Percutaneous Coronary Intervention for Left Main Narrowings (from the Milan and New-Tokyo Registry) 8
Impact of membranous septum length on pacemaker need with different transcatheter aortic valve replacement systems: The INTERSECT registry 8
Provisional Strategy for Left Main Stem Bifurcation Disease: A State-of-the-Art Review of Technique and Outcomes 8
Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience 8
Totale 1.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 2 0 0 5 3 0 0 0 0 2 0 0
2020/202122 0 0 0 4 0 16 1 0 1 0 0 0
2021/202279 0 0 0 40 4 2 6 7 5 0 4 11
2022/2023964 328 170 45 5 2 83 35 46 18 10 14 208
2023/2024674 124 41 84 38 53 86 6 49 16 15 49 113
2024/2025487 487 0 0 0 0 0 0 0 0 0 0 0
Totale 2.291